세계의 자가 증폭 RNA 합성 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 제품 및 서비스별, 용도별, 최종 사용자별, 지역별, 경쟁(2020-2030년)
Self-amplifying RNA Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1763891
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 자가 증폭 RNA 합성 시장은 2024년에 1억 969만 달러로 평가되었고, 2030년에는 CAGR 19.33%를 나타내 3억 1,712만 달러에 달할 것으로 예측되고 있습니다.
saRNA는 숙주 세포 내에서 자기 복제하는 능력에 의해 대폭 적은 투여량으로 고단백질 발현을 가능하게 함으로써, 기존의 mRNA에 결정적인 우위성을 제공합니다. 이 효율성에 의해 감염증, 종양학, 희소 유전성 질환 등의 치료 분야에서의 이용이 진행되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
1억 969만 달러
시장 규모 : 2030년
3억 1,712만 달러
CAGR : 2025-2030년
19.33%
급성장 부문
바이오메디컬 조사
최대 시장
북미
saRNA는 치료 효과가 장기간 지속되고 필요한 재료가 적기 때문에 백신 개발, 유전자 치료, 암 면역 요법에 특히 매력적인 기술입니다. 기업과 연구기관의 공동연구는 기술 혁신을 더욱 가속화하고 있습니다. 연간 127만명 이상이 사망하고 있는 것으로 추정되는 항균제 내성의 세계의 중하를 감안하면, saRNA는 차세대 백신이나 치료 솔루션에 큰 기대를 걸고 있어, 향후 건강 관리 용도에 있어서의 전략적 중요성을 강조하고 있습니다.
시장 성장 촉진요인
차세대 RNA 치료제 및 백신에 대한 수요 급증
주요 시장 과제
합성 프로토콜의 표준화 부족
주요 시장 동향
모듈식 및 플러그 앤 플레이 플랫폼 개발
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
제품 및 서비스별(제품(프리메이드 saRNA, 효소 및 시약, 기타), 맞춤형 합성 서비스)
용도별(치료제 개발(감염증, 종양학, 기타), 생물의학 연구)
최종 사용자별(제약 및 바이오테크놀러지 기업, 학술 및 연구기관, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 자가 증폭 RNA 합성 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 혼란 : 분쟁, 유행, 무역 장벽
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
GenScript Biotech Corporation
Creative Biogene, Inc.
OZ Biosciences SAS
BOC Sciences
Croyez Bioscience Co. Ltd.
Creative Biolabs, Inc.
Maravai LifeSciences Holdings, Inc.
Areterna LLC
Applied DNA Sciences, Inc.
Moderna, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
The Global Self-amplifying RNA (saRNA) Synthesis Market was valued at USD 109.69 million in 2024 and is projected to reach USD 317.12 million by 2030, registering a CAGR of 19.33%. This market is experiencing rapid growth as the pharmaceutical and biotechnology industries increasingly adopt next-generation RNA technologies. saRNA provides a critical advantage over conventional mRNA by enabling high protein expression at significantly lower doses due to its ability to self-replicate within host cells. This efficiency is driving its use in therapeutic areas such as infectious disease, oncology, and rare genetic disorders.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 109.69 Million
Market Size 2030
USD 317.12 Million
CAGR 2025-2030
19.33%
Fastest Growing Segment
Biomedical Research
Largest Market
North America
The technology's long-lasting therapeutic effects, combined with its lower material requirements, make saRNA especially attractive for vaccine development, gene therapies, and cancer immunotherapy. Investment from CDMOs and pharmaceutical firms is fueling demand for scalable and high-precision synthesis platforms. Collaborations between RNA-focused biotech companies and research institutions are further accelerating innovation. Given the global burden of antimicrobial resistance-estimated to cause over 1.27 million deaths annually-saRNA holds significant promise for next-generation vaccines and treatment solutions, underscoring its strategic importance in future healthcare applications.
Key Market Drivers
Surging Demand for Next-Generation RNA Therapeutics and Vaccines
A major driver of the saRNA synthesis market is the rising demand for advanced RNA-based therapeutics and vaccines. saRNA's self-amplifying mechanism allows for greater protein production using smaller doses than traditional mRNA, reducing overall production costs while improving therapeutic efficacy. This is particularly beneficial in high-priority therapeutic fields such as infectious diseases, rare disorders, and oncology.
The proven success of RNA technologies in clinical settings has strengthened industry confidence and prompted greater integration of saRNA into commercial pipelines. As biopharma companies seek more cost-efficient and potent treatment platforms, saRNA's unique attributes position it as a transformative tool in the future of medicine.
Key Market Challenges
Lack of Standardization in Synthesis Protocols
The absence of standardized protocols is a key challenge impacting the scalability and reproducibility of saRNA production. saRNA molecules are more complex and larger than conventional mRNA, requiring meticulous optimization of synthesis parameters such as capping, dsRNA reduction, and purification techniques.
Inconsistent practices across labs and CDMOs-due to reliance on proprietary processes and varying reagent quality-result in variability in product quality. This variability poses risks during clinical development and limits the ability to establish uniform manufacturing practices across the industry, especially when scaling from research-grade to clinical-grade production.
Key Market Trends
Modular and Plug-and-Play Platform Development
A significant trend shaping the saRNA synthesis market is the advancement of modular and plug-and-play development platforms. These systems are engineered to streamline the design, production, and scalability of saRNA constructs by enabling rapid interchange of functional elements-such as replicase sequences, antigen regions, untranslated regions (UTRs), and capping mechanisms-without needing to alter the core RNA structure.
This flexibility accelerates the development cycle, supports swift adaptation to emerging pathogens or mutations, and enhances efficiency in therapeutic discovery. Such platforms are particularly valuable in addressing rapidly evolving disease targets and are instrumental in improving responsiveness during public health emergencies.
Key Market Players
GenScript Biotech Corporation
Creative Biogene, Inc.
OZ Biosciences SAS
BOC Sciences
Croyez Bioscience Co., Ltd.
Creative Biolabs, Inc.
Maravai LifeSciences Holdings, Inc.
Areterna LLC
Applied DNA Sciences, Inc.
Moderna, Inc.
Report Scope:
In this report, the Global Self-amplifying RNA Synthesis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Self-amplifying RNA Synthesis Market, By Product & Service:
Products
Premade saRNA
Enzymes & Reagents
Others
Custom Synthesis Services
Self-amplifying RNA Synthesis Market, By Application:
Therapeutics Development
Infectious Diseases
Oncology
Others
Biomedical Research
Self-amplifying RNA Synthesis Market, By End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Self-amplifying RNA Synthesis Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Self-amplifying RNA Synthesis Market.
Available Customizations:
Global Self-amplifying RNA Synthesis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Self-amplifying RNA Synthesis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Products {Premade saRNA, Enzymes & Reagents, Others}, Custom Synthesis Services)
5.2.2. By Application (Therapeutics Development {Infectious Diseases, Oncology, Others}, Biomedical Research)
5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Self-amplifying RNA Synthesis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Service
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Self-amplifying RNA Synthesis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Service
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Mexico Self-amplifying RNA Synthesis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Service
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Canada Self-amplifying RNA Synthesis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Service
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Self-amplifying RNA Synthesis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Service
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Self-amplifying RNA Synthesis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Service
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Self-amplifying RNA Synthesis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Service
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Self-amplifying RNA Synthesis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Service
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Self-amplifying RNA Synthesis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Service
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Self-amplifying RNA Synthesis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Service
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Self-amplifying RNA Synthesis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Service
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Self-amplifying RNA Synthesis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Service
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Self-amplifying RNA Synthesis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Service
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. South Korea Self-amplifying RNA Synthesis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Service
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Japan Self-amplifying RNA Synthesis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Service
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Self-amplifying RNA Synthesis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Service
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Self-amplifying RNA Synthesis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Service
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Self-amplifying RNA Synthesis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Service
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Self-amplifying RNA Synthesis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Service
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Self-amplifying RNA Synthesis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Service
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Self-amplifying RNA Synthesis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Service
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Self-amplifying RNA Synthesis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Service
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Self-amplifying RNA Synthesis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Service
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Self-amplifying RNA Synthesis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Service
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
